Timing of onset of antidepressant response with fluoxetine treatment

American Journal of Psychiatry

Volumn 157, Issue 9, 2000, Pages 1423-1428

  Nierenberg, A A ^a   Farabaugh, A H ^a   Alpert, J E ^a   Gordon, J ^a   Worthington, J J ^a   Rosenbaum, J F ^a   Fava, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADULT; AGED; ARTICLE; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033849927     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.9.1423     Document Type: Article

References (34)

1. Clinical findings in the use of Tofranil in depressive and other psychiatric states (1959)
2. The timing, specificity and clinical prediction of tricyclic drug effects in depression
3. Antidepressants: Can we determine how quickly they work? Issues from the literature
4. Why do antidepressants take so long to work?
5. A comparison of the onset of action and therapeutic efficacy of amoxapine and amitriptyline
6. Onset of action of amoxapine and doxepin in outpatients with 'mixed anxiety/depression.'
7. Treatment of depression in outpatients: A controlled comparison of the onset of action of amoxapine and maprotiline
8. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder
9. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder
10. A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder
11. Fixed-dose fluoxetine therapy for depression
12. Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine
13. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression
14. A rating scale for depression
15. Quantifying the speed of symptomatic improvement with electroconvulsive therapy: Comparison of alternative statistical methods
16. How to assess the onset of antidepressant effect: Comparison of global ratings and findings based on depression scales
17. Three-year outcomes for maintenance therapies in recurrent depression
18. Is a cut-off score a suitable measure of treatment outcome in short-term trials in depression? A methodological meta-analysis
19. Heterogeneity of clinical response during placebo treatment
20. Characterizing onset in psychopharmacological clinical trials
21. Nonparametric estimation from incomplete observations
22. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome
23. Initiation and adaptation: A paradigm for understanding psychotropic drug action
24. Identification of true drug response to antidepressants
25. Use of pattern analysis to identify true drug response
26. Different types of placebo response in patients receiving antidepressants
27. Time course of improvement under antidepressant treatment: A survival analytical approach
28. Severity at baseline and onset of improvement in depression: Meta-analysis of imipramine and moclobemide versus placebo
29. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients
30. Methodological problems in the estimation of the onset of the antidepressant effect
31. Speed of onset
32. Are 2-week trials sufficient to indicate efficacy?
33. Analysis of time to stabilization in the treatment of depression: Biological and clinical correlates